In conversation at Veeva Summit: Jonathan Crowther, Pfizer

Digital
Interview with Jonathan Crowther

At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s head of predictive analytics, Jonathan Crowther, to discuss the role of AI in life sciences today.

The video from live onsite at the Veeva Summit explores this broad question, from the differences between supervised, unsupervised, and knowledge-based learning to AI that is both ethical and accessible and propels innovation forward, faster.

Importantly, Crowther discusses the role that partnering with Veeva Link Key People has played for Pfizer in terms of the value chain in clinical trials and clinical operations, leveraging the data to uncover new customer insights, transform analytics, and drive customer-centric business processes. After all, utilising deep data is a critical priority in any biopharma analytics strategy and Veeva Link Key People assists with master data management, so that insight gathering is as efficient and accurate as possible.

Tune into the conversation below, and catch up on previous Veeva Summits: from discussion of declining HCP access to an overview of 2024’s R&D Summit, and closed loop marketing and connectivity – also of interest might be Boehringer Ingelheim’s partnership with Veeva.